The nebulizer market size in the Middle East and Africa is predicted to grow at a steady rate during the forecast period.
Y-O-Y growth in the aging population suffering from chronic diseases in the MEA countries, growing usage of various portable nebulizers, and rising awareness regarding the benefits of the nebulizers propel the MEA nebulizers market demand.
Increasing awareness in healthcare providers regarding innovative products boosts the nebulizer market growth in the Middle East and Africa. Growing funds and investments by public and private organizations for research and development activities, increasing FDA approvals for the product launches are expected to promote the market's growth rate. The burgeoning number of COVID-19 patients with emergency care hospitalized has favored the market. The key market participants make strategic plans with acquisitions and collaborations to increase their market share.
With the rising number of asthma cases in children and adults, various advantages provided by portable devices and easy availability of these devices are expected to accelerate the growth pace in the MEA region. The rising consumption of alcohol, intake of cigarettes and other products, and increasing demand for home healthcare products accumulate the market growth rate over the historic period.
However, lack of awareness in people in the developing countries of MEA and the shortage of skilled professionals limit the market development. The loss of drug during the nebulization process, strict government norms for the product approvals hinders the market’s growth rate. Moreover, the presence of alternate solutions, side-effects associated with the key used in the nebulizer hampers the market demand.
Impact of COVID-19 MEA Nebulizer Market:
The sudden eruption of COVID 19 led to the escalation in nebulizers’ devices, including other respiratory devices. As of now, there is no vaccine available for the virus. The demand for emergency medical devices such as respiratory devices plays a crucial role in pain management among patients suffering from COVID-19. Pharmaceutical companies are concentrating on developing effective treatment therapies for the virus infection. The positive response from the clinical study is projected to flourish the nebulizer market growth. Aged people are more exposed to the virus spread and require emergency care in hospitals. The demand for home care nebulizers is also increasing.
The MEA Nebulizer Market Research Report has been segmented and sub-segmented into the following categories.
Geographically, the nebulizer market in Middle East & Africa is to have a stable growth rate due to the growing number of respiratory diseases and rising COPD. In 2018, as per the National Center for Biotechnology Information, the occurrence of asthma in Middle East countries varied from 4.4% to 7.6%. The rising healthcare payments boost the market growth. UAE nebulizers market is awaited to grow with the highest CAGR rate. The increase in UAE is due to mushrooming occurrences of respiratory disorders like sleep apnea, TB, and asthma. The deepening advancements in technology, a huge patient count, and the growing number of COPD cases surge the nebulizers market growth. As per the Global Health Data Exchange, in 2017, around 19,742.18 people are affected with Chronic Pulmonary Obstructive disease in UAE. In UAE, a large number will demand more for respiratory devices to drive the market growth rate.
Other countries such as KSA and Israel are anticipated to have considerable market growth rates. The increasing government initiatives by the governments as well as private organizations intensify the market growth. The rising adoption of the portable nebulizer and many players' presence and surging incidences of chronic respiratory devices aid the nebulizer market development. The growing launch of portable medical nebulizers, rising medical devices, and growing older people strengthens the market's demand.
KEY MARKET PLAYERS:
Briggs Healthcare, Besco Medical, Ca-Mi, De Vilbiss Healthcare, Feellife Health, Flyp, Invacare, Omron, Philips Respironics, and Pari Medical are expected to play a significant role in the MEA nebulizers market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]